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The aim of this study was to optimize fluid bed granulation and tablets compression processes using design space approach. Type
of diluent, binder concentration, temperature during mixing, granulation and drying, spray rate, and atomization pressure were
recognized as critical formulation and process parameters. They were varied in the first set of experiments in order to estimate
their influences on critical quality attributes, that is, granules characteristics (size distribution, flowability, bulk density, tapped
density, Carr’s index, Hausner’s ratio, and moisture content) using Plackett-Burman experimental design. Type of diluent and
atomization pressure were selected as the most important parameters. In the second set of experiments, design space for process
parameters (atomization pressure and compression force) and its influence on tablets characteristics was developed. Percent of
paracetamol released and tablets hardness were determined as critical quality attributes. Artificial neural networks (ANNs) were
applied in order to determine design space. ANNs models showed that atomization pressure influences mostly on the dissolution
profile, whereas compression force aﬀects mainly the tablets hardness. Based on the obtained ANNsmodels, it is possible to predict
tablet hardness and paracetamol release profile for any combination of analyzed factors.
1. Introduction
1.1. Quality by Design (QbD). Recently proposed quality-by-
design (QbD) regulatory initiative of pharmaceutical prod-
uct and process development has encouraged researchers in
pharmaceutical industry to reach the “desired state” of drug
manufacturing in 21st century. Main goal of this approach
is to gain a comprehensive understanding of their man-
ufacturing processes, with an accurate estimation of their
robustness and reliability. The emphasis has changed from
the need to demonstrate that the product will consistently
meet relatively tight specifications to a new situation of being
able to demonstrate that the product is controlled within a
broader “design space” (DS). The design space (DS) concept
is introduced as “the multidimensional combination and
interaction of input variables (e.g., materials attributes) and
process parameters that have been demonstrated to provide
assurance of quality.” Using this approach, it is essential
to define relationship between critical formulation/process
parameters and critical quality attributes (such as granule
characteristics and tablet properties) [1, 2].
1.2. Fluid Bed Granulation. Wet granulation is a process
of small particles agglomeration into larger, relatively per-
manent structures in which the original particles can still
be identified [3]. In fluid bed granulation process, binder
solution is usually sprayed in form of the fine droplets onto
powder mass in state of fluidization. It is a very complex pro-
cess influenced by many factors. These factors are classified
into three groups: formulation factors, process parameters,
and equipment related factors. Their numerous interactions
make the process optimization much more diﬃcult [4].
The influence of process parameters and formulation
factors on the fluid bed granulation process has been studied
extensively in the last few years. The most widely studied
formulation factors are type of diluent and binder and
concentration of the binder solution. The previous studies
proved that, when hydrophilic diluents were used, large-size
granules were obtained. This is a result of better wetting of
powder mass and consequently faster granules growth [4, 5].
An increase in the binder concentration decreases duration
of granulation [6–8]. Higher values of Carr’s index and
Hausner’s ratio, which point to poor flowability, are recorded
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Figure 1: Schematic drawing of multilayer perceptron neural
networks [16].
when higher binder concentration was used [8, 9]. The
most extensively studied process parameters are atomization
pressure, air flow rate, temperature and humidity of inlet
air, and spray rate. It has been shown that increase in the
atomization pressure leads to decrease in the binder droplet
size [7, 10]. In most studies [9–12], granules size increased
with decrease in atomization pressure. Small-size granules
were obtained when high air flow rate was used, because
of the more intensive breakage and faster evaporation of
binder solution [7, 11–13]. Increase in the spray rate leads
to the increase in granules size because of the larger droplet
size, improved powder mass wetting, and formation of more
bonds between the particles [7, 13, 14]. The decrease in
granule size was recorded with higher inlet air temperature,
because of the faster binder evaporation [11]. Inlet air
humidity has the opposite eﬀect; increase in this parameter
leads to the increase in granules size as well [15].
1.3. Artificial Neural Networks. Artificial neural networks
(ANNs) are computer programs designed to simulate some
of the human brain functions such as learning, ability to
generalize, and draw conclusions from the gained experience.
Application of artificial neural networks is a new dimen-
sion in the formulation of drugs because of the unique
advantages such as nonlinearity, the ability of modeling and
optimization with a small set of experiments. ANNs are not
programmed, they learn from the presented solved problems.
Using diﬀerent algorithms for learning, they recognize the
relationships and patterns within the data presented to them
and thus acquire the ability to predict responses to new
experimental conditions. The ability of neural networks to
generalize the problem is one of the strongest motivations
for research in this area [16].
The way in which the neurons are interconnected is
referred to as a “network architecture” or “topology.” A
variety of network architectures has been developed for
diﬀerent applications, but one of the most common is a
multilayer perceptron (MLP) network (Figure 1) in which
the neurons are organized into layers. The first layer is called
the input layer and has no ability to generate the data. It
serves for the transmission of input values to the first hidden
layer. The inputs are simply the input variables, such as
ingredients, ingredient amounts, and processing conditions.
The last layer is used to process the output values of the
dependent variables such as in vitro drug release profile and
is called the output layer. Between these two layers, there are
hidden layers that are used to enable connections between
the input and output layers. The complexity of the problem
determines the number of the hidden layer neurons. This
is a “feed forward” network, which means that information
is passed in one direction through the network from the
inputs, through various hidden layers to the outputs. If
set of inputs variables is provided, the ANNs model can
be used to predict the response such as critical quality
attribute of the product. Well-trained models can answer the
questions like “what if ?” or “what kind of re lease profile
can be expected with changing excipients concentration?”
[16]. Artificial neural networks can be successfully used in
pharmaceutical formulations optimization [17–22].
The aim of our study was to define the design space of
fluid bed granulation and tablet compression process. In the
first part, the assessment of process and formulation factors
(critical material and process parameters) and their influence
on granules characteristics (critical quality attributes) was
performed. Optimal variables values from the first set of
experiments were used in the second set, while atomization
pressure and compression force were varied, in order to
develop new design space, evaluating their influence on
tablets characteristics.
2. Materials and Methods
2.1. Materials. Materials used in the presented study for the
granulation and tabletting experiments were: paracetamol
(Ph.Eur. 7.0), polyethylene oxide (Polyox WSR Coagulant,
Dow Chemical, USA, USP30-NF25), anhydrous lactose
(Ph.Eur. 7.0), microcrystalline cellulose (Vivapur Type 101,
J. Rettenmaier & So¨hne GmbH, Germany, Ph.Eur. 7.0), and
purified water (Aqua purificata, Ph.Eur. 7.0).
2.2. Wet Granulation Process. The granulation was per-
formed in the fluid bed granulator Mycrolab (Hu¨ttlin,
Germany). Diluent type, binder (polyethylene-oxide) con-
centration, temperature during mixing and granulation, air
flow rate during mixing, granulation and drying, spray rate,
and atomization pressure were varied on two levels (Table 1).
Anhydrous lactose or microcrystalline cellulose was used as
diluent. Polyethylene-oxide was used as a binder, whereas
purified water was used as the binder solvent. For each
experimental run, 250 g of granules were prepared, with the
granules composition and the processing parameters being
given by the number of experimental run, as represented
in Table 3. Paracetamol was included in formulations in
the second set of experiments. Paracetamol was selected as
a highly water-soluble model drug, in order to investigate
the possibility to obtain its modified release by using
polyethylene oxide polymer as the granules binder. Powder
mass was first mixed in the granulator for 5min. After this,
water was sprayed onto the powder mass (containing diluent
and polyethylene-oxide) from the bottom of the chamber
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Table 1: Dependent variables in the first set of experiments.
Factor (variable) Symbol Low level (−1) High level (+1)
Type of diluent X1 Anhydrous lactose Microcrystalline cellulose
Concentration PEO1 X2 5 10
Temperature during mixing and granulation (◦C) X3 55 65
Air flow rate during mixing (m3/h) X4 20 30
Air flow rate during drying (m3/h) X5 20 30
Spray rate (g/min) X6 5 10
Atomization pressure (bar) X7
Spray air 0.5 Spray air 1.0
Microclimate 0.25 Microclimate 0.5
1
PEO: polyethylene-oxide.
Table 2: Plackett-Burman experimental design (coded values).
No. exp. X1 X2 X3 X4 X5 X6 X7
1 −1 −1 −1 +1 −1 +1 +1
2 +1 −1 −1 −1 +1 −1 +1
3 +1 +1 −1 −1 −1 +1 −1
4 −1 +1 +1 −1 −1 −1 +1
5 +1 −1 +1 +1 −1 −1 −1
6 −1 +1 −1 +1 +1 −1 −1
7 −1 −1 +1 −1 +1 +1 −1
8 +1 +1 +1 +1 +1 +1 +1
in the half amount of powder mass. The granulation phase
lasted until the whole amount of water was spent. Then,
when the product temperature started to rise, the inlet air
temperature was set on 0◦C in order to cool the product.
2.3. Design of Experiments. Plackett-Burman experimental
design was used to investigate the influence of formulation
and process variables on the granules and tablets charac-
teristics. Coded variables values are given in the Table 2.
Experimental plan was obtained after replacing coded with
real variables values (Table 3). The result of each experiment
is a linear combination of variables eﬀects:
y =β0 + β1X1 + β2X2 + β3X3 + β4X4 + β5X5
+ β6X6 + β7X7 + ε.
(1)
As eight experiments were performed, the system of eight
linear equations was obtained. Coeﬃcients β1,β2, . . . ,β7
show how much each of the seven variables influences on
granules characteristics. Their values were calculated using
Design Expert software (Stat-Ease, USA).
2.4. Granules Characterization
2.4.1. Granules Size Distribution. Granules size distribution
was determined by the sieve analysis method [23]. A 100-g
granule sample was transferred to the set of sieves (180, 315,
and 500 μm size) and shaken for 10min. After 10 minutes
of sieving, the fractions of granules retained on each sieve
were weighed and these weights were converted into mass
percentages.
2.4.2. Flowability. Granules flowability was determined by
the oﬃcial method [23]. A 50 g sample of granules was
transferred to the flow testing device (Flow meter GDT,
Erweka, Germany), and the time needed for sample flowing
through an orifice of 12mm in diameter was measured. The
flowability was expressed as a flow rate which was calculated
from the ratio of sample mass andmeasured time. Results are
expressed as the mean value of three replicates.
2.4.3. Bulk Density. Bulk density was determined in the
graduated 50mL cylinder. 15 g of sample was measured and
poured into cylinder. The bulk density was calculated as the
ratio of granules mass and read volume.
2.4.4. Tapped Density. After determination of the bulk
density, graduated cylinder was exposed to agitation and
mild striking to the solid surface. The number of taps varied
depending on the diﬀerences in the granules volume after
agitation. Once the volume did not change significantly,
striking was stopped. The number of taps did not exceed 100.
Tapped density was calculated as the ratio of granules mass
and read volume after agitation.
2.4.5. Hausner’s Ratio. Hausner’s ratio was calculated using
the formula:
Hausner′s ratio = tapped density
bulk density
(2)
(see [23]).
2.4.6. Carr’s Ratio. Carr’s ratio was calculated using the
formula
Carr′s ratio =
(
trapped density− bulk density)
trapped desity (3)
(see [23]).
2.4.7. Moisture Content. The granules moisture content was
determined gravimetrically on a Chyo 91 device (Chyo,
USA). A certain sample mass was transferred to the device,
and after 30min of warming with the lamp at 105◦C, the
moisture content was read from the display.
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Table 3: Experimental plan for the first set of experiments.
No. exp. X1 X2 (%) X3 (◦C) X4 (m3/h) X5 (m3/h) X6 (g/min) X7 (bar)
1 Anhydrous lactose 5 55 30 20 10 1.0/0.5
2 Microcrystalline cellulose 5 55 20 30 5 1.0/0.5
3 Microcrystalline cellulose 10 55 20 20 10 0.5/0.25
4 Anhydrous lactose 10 65 20 20 5 1.0/0.5
5 Microcrystalline cellulose 5 65 30 20 5 0.5/0.25
6 Anhydrous lactose 10 55 30 30 5 0.5/0.25
7 Anhydrous lactose 5 65 20 30 10 0.5/0.25
8 Microcrystalline cellulose 10 65 30 30 10 1.0/0.5
X1: type of diluent.
X2: binder (polyethylene-oxide) concentration (%).
X3: temperature during mixing and granulation (◦C).
X4: air flow rate during mixing (m3/h).
X5: air flow rate during drying (m3/h).
X6: spray rate (g/min).
X7: atomization pressure (bar).
Table 4: Experimental plan for the second set of experiments.
Formulation
Atomization pressure, Compression
spray air (bar) force (kN)
Ft1 0.5 3.5
Ft2 0.75 3.5
Ft3 1.0 3.5
Ft4 0.5 3.75
Ft5 0.75 3.75
Ft6 1.0 3.75
Ft7 0.5 4.0
Ft8 0.75 4.0
Ft9 1.0 4.0
2.5. Tablets Preparation. Fluid bed granulation and tabletting
of obtained granules on eccentric tablet machine was
performed in the second set of experiments. Optimal values
of formulation and process factors (X1–X6, Table 1.) were
defined by analyzing their influence on granules characteris-
tics in the first set of experiments. Atomization pressure (X7,
Table 1) and tablet compression force were varied on three
levels in the second set of experiments. Nine formulations
(Ft1–Ft9, Table 4) were prepared. The mass of tablets was
500mg each, while the paracetamol content was 100mg per
tablet.
2.6. Tablets Characterization
2.6.1. Resistance to the Crushing of Tablets. This test is
intended to determine, under defined conditions, the resis-
tance to crushing of tablets, measured by the force needed
to disrupt them by crushing. Resistance to crushing of
tablets was determined on Erweka TB24 (Erweka, Germany),
measuring the force that leads to the tablet fracture. Results
are expressed as the mean value of 10 replicates.
2.6.2. Dissolution Testing. Dissolution testing was performed
in the rotating paddle apparatus (Erweka DT70, Germany).
Phosphate buﬀer (pH = 5, 8, USP30-NF25) in the volume of
900mL was used as a medium, and the rotating paddle speed
was 50 rpm. Medium temperature was maintained on 37◦C
to simulate physiological conditions. Sampling was carried
out at 5, 10, 20, 30, 45, 60, 90, 120, 150, and 180 minutes,
and the absorbance of paracetamol was measured at 243 nm
by the UV/VIS spectrophotometer Evolution 300 (Thermo
Fisher Scientific, Cambridge, UK). Results are expressed as
the mean value of three replicates.
2.6.3. Analysis of Results Using Artificial Neural Networks.
Inform software (Intelligensys, UK) was used to analyze
the results of the second set of experiments. The input
parameters (independent variables) were atomization pres-
sure and compression force. Tablets hardness and percentage
of paracetamol released after 5, 10, 20, 30, 45, 60, 90, 150
and 180 minutes were determined as outputs (dependent
variables). ANN used in the study was of the multilayer
perceptron (MLP) type with the backpropagation learning
algorithm.
3. Results and Discussion
3.1. Influence of the Formulation and Process Parameters
on Granules Characteristics. Characterization of obtained
granules was performed after granulation. Granules size
distribution, flowability, bulk and tapped density, Hausner’s
ratio, Carr’s index, and granules moisture content were
determined as product characteristics. The results of the first
set of experiments are given in the Table 5.
The aim was to obtain uniform granules of medium
size. The target size was between 180 and 500 μm. Granules
smaller than 180 μm tend to have greater cohesiveness, higher
Hausner’s index, and lower compressibility. Therefore, high
percent of this fraction is not desired. The purpose of gran-
ulation is to improve the flow properties of powder mix, so
high flow rates are desired. As it can be seen from the Table 5,
flow rates were very variable. Granules obtained from
experiment three were not flowable. This experiment was
not successful because the powder was overwetted. Earlier
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Table 5: Granules characterization.
Y1
Y2 Y3 Y4 Y5 Y6 Y7
d < 180 180 < d < 315 315 < d < 500 d > 500
1 52.82 39.75 7.38 0.05 7.28 ± 0.6 0.625 0.750 1.20 16.67 1.4
2 97.84 1.86 0.30 0.00 2.90 ± 0.2 0.385 0.517 1.34 25.53 3.9
3 74.31 10.28 6.44 8.97 0.00 0.341 0.468 1.37 27.14 10.1
4 52.73 39.57 7.64 0.06 7.54 ± 0.5 0.600 0.750 1.25 20.00 0.9
5 97.38 2.22 0.40 0.00 2.50 ± 0.2 0.366 0.517 1.41 29.21 3.2
6 35.14 47.97 16.64 0.25 6.02 ± 0.4 0.555 0.682 1.23 18.62 1.0
7 17.72 48.04 33.47 0.78 6.55 ± 0.4 0.469 0.600 1.28 21.83 3.0
8 93.39 5.79 0.83 0.00 2.83 ± 0.2 0.395 0.536 1.36 26.31 3.2
Y1: granules size distribution (%).
Y2: flowability (g/s).
Y3: bulk density (g/mL).
Y4: tapped density (g/mL).
Y5: Hausner’s ratio.
Y6: Carr’s index (%).
Y7: moisture content (%).
Table 6: Analysis of inf luence formulation and process factors on granules properties.
Granules size distribution Flowability Bulk Tapped Hausner Carr’s Moisture
<180 180–315 315–500 >500 density density ratio index content
Type of diluent (β1) 25.5638 −19.3975 −7.145 0.9788 −2.84 −0.095 −0.09125 0.065 3.9163 1.7625
Concentration of
PEO (β2)
−1.2737 1.4675 −1.25 1.05625 −0.355 0.00525 0.00525 −0.0025 −0.1563 0.4625
Temperature during
mixing and
granulation (β3)
0.1388 −0.53 1.4475 −1.0538 0.4025 −0.0075 −0.00125 0.02 1.1588 −0.7625
Air flow rate during
mixing (β4)
4.5163 −0.5025 2.825 −1.1888 0.205 0.0175 0.01875 −0.005 −0.4888 −1.1375
Air flow rate during
drying (β5)
−4.1437 1.48 3.6725 −1.0063 0.1225 −0.0175 −0.01875 −0.0025 −0.0937 −0.0563
Spray rate (β6) −5.6062 1.53 −2.8925 1.1863 0.2875 −0.01 −0.01375 −0.0025 −0.1738 1.0875
Atomization pressure
(β7)
9.0288 −2.6925 −5.1 −1.2363 0.685 0.0325 0.03625 −0.0175 −1.0513 −0.9875
study [11] showed that combination oflow air flow rate,
low inlet air temperature, and high spray rate, such as in
this experiment, is associated with high risk of overwetting
and defluidization. Also, hydrophobic substances such as
microcrystalline cellulose are more susceptible to overwet-
ting than hydrophilic ones like anhydrous lactose. Hausner’s
ratio lower than 1.34 and Carr’s index lower than 25%
were considered to be acceptable [23]. Higher values that
indicate poorer flowability and compressibility are recorded
in experiments where granules smaller than 180 μm were
obtained in high percentage (Table 5). The moisture content
values less than 3.5% were considered to be acceptable.
Except experiments 2 and 3, all experiments gave granules
with acceptable moisture content.
The analysis of influence of formulation and process
factors on granules properties is shown in the Table 6. The
diluent type has the strongest influence on each examined
characteristic. The fraction of granules with size between 180
and 500 μm increases when anhydrous lactose is selected as a
diluent. Granules smaller than 180 μm were obtained in high
percentage using microcrystalline cellulose as diluent. This is
in concordance with earlier results, which showed that larger
granules were obtained when hydrophilic diluents were used
[5, 6]. Better flowability and lower moisture content also
support the choice of anhydrous lactose as a diluent. The
second significant factor is atomization pressure. Larger
granules were obtained when lower atomization pressure was
used in the process. The same results are recorded in earlier
studies [9–12]. But, unexpectedly, granules flowability was
not improved with decrease in the atomization pressure. This
may be explained with higher moisture content at lower at-
omization pressure, which increases cohesiveness, and may
decrease flowability. For better evaluation of the impact of
atomization pressure, this parameter was varied on three
levels in the second set of experiments. The temperature
during mixing and granulation has the significant influence
only on the Carr’s index and Hausner’s ratio. Higher values
of these parameters, which indicate to poor flowability and
compressibility, are recorded at higher temperature which
is in agreement with earlier results [9]. Other process para-
meters have less significant influence on granules properties.
After analysis of factors influence on the granulation process,
process and formulation variables that gave granules with
desired properties were chosen: anhydrous lactose as a
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Figure 2: Dissolution profiles of paracetamol from nine tablets
series.
diluent, higher polyethylene-oxide concentration (10%),
lower temperature during mixing and granulation (55◦C),
lower air flow rate during mixing and granulation (20m3/h),
lower air flow rate during drying (20m3/h), higher spray
rate (10 g/min). These values were used in the second set of
experiments, while atomization pressure was varied on three
levels.
3.2. Results of the Second Set of Experiments
3.2.1. Tablets Hardness Testing. Results of tablets hardness
testing are given in the Table 7. According to results, tablets
hardness is very variable, in the range of 3.68N to 118.21N,
which could have influence on drug release and physical
stability of tablets as well.
3.2.2. Drug Release Profiles from Tablets. Percentages of
released paracetamol in diﬀerent time intervals during 3
hours are given in Table 8. Dissolution profiles are very
diﬀerent (Figure 2). Formulations Ft1, Ft2, Ft4, and Ft7
showed immediate release (after 30min, over 80% of
paracetamol has been released), while formulations where
atomization pressure during granulation was 1 bar showed
modified release profiles. Percentage of released paracetamol
after 30min varied from 18.12% (Ft9) to 83.30% (Ft2).
3.2.3. Analysis of the Influence of Atomization Pressure and
Compression Force on Tablets Hardness Using ANNs. Using
ANNs, it is possible to visualize dependent variables (tablets
hardness and percentage of released paracetamol in diﬀerent
periods of time during 3 h) in function of independent
variables (atomization pressure and compression force) by
3D diagrams. It is possible to predict responses in all points
of experimental field, because the software finds “ideal”
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Figure 3: Tablets hardness changing in function of independent
variables (atomization pressure and compression force).
formulation, and further experiments are not necessary.
Figure 3 shows changing of tablets hardness in function of
independent variables (atomization pressure and compres-
sion force).
3D diagram from Figure 3 shows that atomization pres-
sure has less influence on tablets hardness in comparison to
the compression force used for tablet manufacturing. Also,
increasing compression force, tablets hardness increased as
well.
3.2.4. Analysis of the Influence of Atomization Pressure and
Compression Force on Paracetamol Release from Tablets Using
ANNs. Figure 4 presents 3D diagrams which describe the
influence of compression force and atomization pressure
on paracetamol release. It is clearly seen that both of
parameters have influence on release profile, but the impact
of atomization pressure is much stronger. The percent of
released paracetamol decrease with increasing of atomization
pressure and compression force. From obtained results, it
may be concluded that high atomization pressure (1 bar) is a
good way to achieve modified release of paracetamol from
tablets, while increasing of compression force may further
support this aim.
The main advantage of these models is the possibility
to predict drug release and tablets hardness for any com-
bination of atomization pressure and compression force in
each point of experimental field. Figure 5 shows the contour
plot describing the influence of atomization pressure and
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Figure 4: Continued.
8 The Scientific World Journal
90
m
in
Com
pression
force
Atom
izati
on p
ressu
re
20
30
40
50
60
70
80
90
100
110
3.4
3.5
3.6
3.7
3.8
3.9
4
4.1
1.1
1
0.9
0.8
0.7
0.6 0.5
0.4
>90
<90
<80
<70
<60
<50
<40
<30
<20
(Y)
(Z
)
(X)
(g)
12
0
m
in
Com
pression
force
Atom
izati
on p
ressu
re
30
40
50
60
70
80
90
100
110
3.4
3.5
3.6
3.7
3.8
3.9
4
4.1
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
>100
<100
<90
<80
<70
<60
<50
<40
<30
(X)
(Y)
(Z
)
(h)
15
0
m
in
Com
pression
force
Atom
izati
on p
ressu
re
40
50
60
70
80
90
100
110
3.4
3.5
3.6
3.7
3.8
3.9
4
4.1
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
>100
<100
<90
<80
<70
<60
<50
(Y
)
(X)
(Z
)
(i)
Com
pression
force
50
60
70
80
90
100
110
3.4
3.5
3.6
3.7
3.8
3.9
4
4.1
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
>100
<100
<90
<80
<70
<60
<50
180m
in
Z
(Y)
(Z)
(j)
Figure 4: Percent of released paracetamol after 5 (a), 10 (b), 20 (c), 30 (d), 45 (e), 60 (f), 90 (g), 120 (h), 150 (i), and 180 (j) minutes in
function of independent variables (atomization pressure and compression force).
Table 7: Results of tablets hardness testing.
Compression force 3.5 kN Compression force 3.75 kN Compression force 4 kN
Atomization pressure 0.5 bar 0.75 bar 1 bar 0.5 bar 0.75 bar 1 bar 0.5 bar 0.75 bar 1 bar
Hardness (N) 3.68 26.09 5.59 68.57 84.37 47.48 100.75 118.21 53.96
compression force on the percent of paracetamol released
after 30min. It is obvious, that, in wide range of process
parameters, the percent of released paracetamol is less than
80%. This shows that polyethylene-oxide delayed release of
active substance, which is its purpose in hydrophilic matrix
systems.
3.2.5. Predicting Independent Variables (Compression Force
and Atomization Pressure) Based on Desired Values of Tablet
Hardness and Percentage of Released Paracetamol in Diﬀerent
Time Periods during 3 h Using ANNs. Besides potentially
predicting output parameters, it is possible to predict input
parameters based on assigned output parameters. First, the
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Table 8: The percentage of paracetamol released from tablets in diﬀerent time interval during 3 hours.
Compression force 3.5 kN Compression force 3.75 kN Compression force 4 kN
Time
(min)
A.P. 0.5 bar A.P. 0.75 bar A.P. 1 bar A.P. 0.5 bar A.P. 0.75 bar A.P. 1 bar A.P. 0.5 bar A.P. 0.75 bar A.P. 1 bar
5 67.21 ± 1.94 75.47 ± 3.52 5.81 ± 0.93 76.35 ± 5.18 60.06 ± 9.26 7.61± 1.96 47.48 ± 4.23 38.74 ± 1.66 5.37 ± 0.15
10 75.05 ± 2.01 78.91 ± 6.75 11.04 ± 3.19 78.77 ± 4.39 67.20 ± 4.42 12.35± 2.87 60.83 ± 5.01 38.71 ± 5.20 8.91 ± 0.11
20 78.83 ± 0.23 81.68 ± 3.82 22.11 ± 8.94 82.39 ± 11.27 70.67 ± 4.53 20.67± 6.97 80.68 ± 7.25 45.16 ± 13.08 14.74 ± 0.34
30 79.70 ± 5.90 83.30 ± 3.28 28.13 ± 6.86 76.92 ± 3.57 66.91 ± 5.32 21.81± 9.07 80.59 ± 6.05 54.54 ± 16.07 18.12 ± 1.88
45 83.25 ± 1.21 87.34 ± 3.35 34.62 ± 11.67 79.67 ± 2.69 74.96 ± 2.56 30.61±13.00 87.18 ± 2.35 69.79 ± 15.05 22.41 ± 1.45
60 85.87 ± 1.22 90.77 ± 1.46 39.80 ± 11.24 84.21 ± 4.40 73.26 ± 7.55 36.18 ± 10.72 85.20 ± 3.84 69.93 ± 14.56 29.03 ± 1.50
90 88.50 ± 1.96 93.93 ± 2.02 50.65 ± 12.73 80.43 ± 11.71 78.09 ± 6.81 44.98 ± 12.02 79.69 ± 5.56 75.31 ± 10.91 41.61 ± 1.21
120 93.75 ± 0.55 96.35 ± 0.02 57.85 ± 12.54 77.99 ± 2.56 85.56 ± 8.07 51.94 ± 12.02 84.69 ± 9.95 75.68 ± 10.67 51.22 ± 0.19
150 96.46 ± 2.53 97.46 ± 3.08 69.80 ± 12.22 78.73 ± 4.96 80.51 ± 3.10 58.44 ± 10.66 84.75 ± 4.89 77.31 ± 7.31 59.24 ± 0.88
180 97.00 ± 1.88 98.00 ± 2.95 62.25 ± 8.66 83.49 ± 8.60 79.33 ± 9.33 62.87 ± 10.00 86.19 ± 6.33 79.86 ± 7.61 64.89 ± 1.71
A.P.: atomization pressure.
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Figure 5: Contour plot which describes the influence of atom-
ization pressure and compression force on the percent of released
paracetamol after 30min.
information of desired output parameters is being given to
the network, and then the network defines their real values
and predicts optimal values of input parameters.
The range between minimum and maximum values of
desired output parameters is shown in the Table 9. Based on
these desired values, defined by the user, network predicts
optimal values. In the end, ANN provides the optimal values
of input parameters for achieving the desired outputs as
in this case atomization pressure of 1 bar and tabletting
compression force of 3.66 kN.
4. Conclusion
Based on obtained ANNs models, it is possible to predict
tablet hardness and released profile of paracetamol for any
Table 9: The prediction of input parameters based on desired
values of outputs.
Desired output parameters Predicted
parametersMin Max
Hardness (N) 60 80 61.83
Percent of released paracetamol in diﬀerent time intervals (%)
5min 5 10 15.99
10min 10 15 16.55
20min 15 20 18.83
30min 20 25 23.67
45min 25 35 30.39
60min 35 45 38.23
90min 45 55 49.98
120min 55 65 59.85
150min 65 80 67.82
180min 80 90 63.34
combination of analyzed factors. This defines design space
for fluid bed wet granulation process with paracetamol as
an active substance, polyethylene-oxide as a binder, and also
design space of obtained granules tabletting process. Quality-
by-design approach provides complete knowledge of the
process, process control, and observing the principles that
“the quality is not being tested, it is built into the product.”
With the development of new user-friendly software
package, the growing use of ANNs in design and develop-
ment of new medicinal preparations is expected. This will
also enable the quick and easy evaluation of stability, safety,
and eﬃcacy of drugs, with greatly costs reducing.
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